BACKGROUND: Chlorothalonil is a broad spectrum, non-systemic fungicide widely used to control diseases affecting over 50 fruit, vegetable, and agricultural crops. Despite its extensive use for over 30 years, little is known about the potential human carcinogenicity associated with the routine application of chlorothalonil. Rodent studies have shown evidence of renal tubular carcinomas and adenomas. We explored cancer incidence with chlorothalonil exposure using data from the Agricultural Health Study, a prospective cohort of licensed pesticide applicators in Iowa and North Carolina. METHODS: Licensed private and commercial pesticide applicators were recruited into this study from 1993 to 1997. Detailed information regarding pesticide use was obtained via self-administered questionnaires. Cancer incidence was followed through December 31, 2004. Chlorothalonil exposure was classified by lifetime exposure days and intensity-weighted lifetime exposure days, and then categorized into tertiles. The intensity-weighted lifetime exposure days metric was calculated based on a complex algorithm which includes pesticide application methods among other factors. This may increase or decrease exposure. RESULTS: Of the 47,625 pesticide applicators included in this analysis, 3657 applicators reported using chlorothalonil with a median of 3.5 application days per year. Chlorothalonil was not associated with overall cancer incidence, nor did we find any association with colon, lung, and prostate cancers--the only cancers for which we had sufficient numbers to explore associations. CONCLUSION: We did not find any strong evidence for an association between chlorothalonil and the cancers investigated. Although animal studies have suggested renal cancer may be associated with chlorothalonil, we had insufficient data to evaluate this cancer.
BACKGROUND:Chlorothalonil is a broad spectrum, non-systemic fungicide widely used to control diseases affecting over 50 fruit, vegetable, and agricultural crops. Despite its extensive use for over 30 years, little is known about the potential human carcinogenicity associated with the routine application of chlorothalonil. Rodent studies have shown evidence of renal tubular carcinomas and adenomas. We explored cancer incidence with chlorothalonil exposure using data from the Agricultural Health Study, a prospective cohort of licensed pesticide applicators in Iowa and North Carolina. METHODS: Licensed private and commercial pesticide applicators were recruited into this study from 1993 to 1997. Detailed information regarding pesticide use was obtained via self-administered questionnaires. Cancer incidence was followed through December 31, 2004. Chlorothalonil exposure was classified by lifetime exposure days and intensity-weighted lifetime exposure days, and then categorized into tertiles. The intensity-weighted lifetime exposure days metric was calculated based on a complex algorithm which includes pesticide application methods among other factors. This may increase or decrease exposure. RESULTS: Of the 47,625 pesticide applicators included in this analysis, 3657 applicators reported using chlorothalonil with a median of 3.5 application days per year. Chlorothalonil was not associated with overall cancer incidence, nor did we find any association with colon, lung, and prostate cancers--the only cancers for which we had sufficient numbers to explore associations. CONCLUSION: We did not find any strong evidence for an association between chlorothalonil and the cancers investigated. Although animal studies have suggested renal cancer may be associated with chlorothalonil, we had insufficient data to evaluate this cancer.
Authors: Aaron Blair; Robert Tarone; Dale Sandler; Charles F Lynch; Andrew Rowland; Wendy Wintersteen; William C Steen; Claudine Samanic; Mustafa Dosemeci; Michael C R Alavanja Journal: Epidemiology Date: 2002-01 Impact factor: 4.822
Authors: Mustafa Dosemeci; Michael C R Alavanja; Andrew S Rowland; David Mage; Shelia Hoar Zahm; Nathaniel Rothman; Jay H Lubin; Jane A Hoppin; Dale P Sandler; Aaron Blair Journal: Ann Occup Hyg Date: 2002-03
Authors: M C Alavanja; D P Sandler; S B McMaster; S H Zahm; C J McDonnell; C F Lynch; M Pennybacker; N Rothman; M Dosemeci; A E Bond; A Blair Journal: Environ Health Perspect Date: 1996-04 Impact factor: 9.031
Authors: Kannan Badri Narayanan; Manaf Ali; Barry J Barclay; Qiang Shawn Cheng; Leandro D'Abronzo; Rita Dornetshuber-Fleiss; Paramita M Ghosh; Michael J Gonzalez Guzman; Tae-Jin Lee; Po Sing Leung; Lin Li; Suidjit Luanpitpong; Edward Ratovitski; Yon Rojanasakul; Maria Fiammetta Romano; Simona Romano; Ranjeet K Sinha; Clement Yedjou; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Elizabeth P Ryan; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Hosni K Salem; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Seo Yun Kim; William H Bisson; Leroy Lowe; Hyun Ho Park Journal: Carcinogenesis Date: 2015-06 Impact factor: 4.944
Authors: Dominik D Alexander; Douglas L Weed; Pamela J Mink; Meghan E Mitchell Journal: Int Arch Occup Environ Health Date: 2011-12-10 Impact factor: 3.015
Authors: Eryn K Matich; Jonathan A Laryea; Kathryn A Seely; Shelbie Stahr; L Joseph Su; Ping-Ching Hsu Journal: Ecotoxicol Environ Saf Date: 2021-05-21 Impact factor: 7.129
Authors: Xiaohui Xu; Amy B Dailey; Evelyn O Talbott; Vito A Ilacqua; Greg Kearney; Nabih R Asal Journal: Environ Health Perspect Date: 2010-01 Impact factor: 9.031
Authors: Ming Ye; Jeremy Beach; Jonathan W Martin; Ambikaipakan Senthilselvan Journal: Int J Environ Res Public Health Date: 2013-11-28 Impact factor: 3.390